Table III.

Correlation of the expression of SATB1 and TLR4 with the clinical and pathological features of patients.

		SATB1			TLR4
Items	Cases (n)	+	χ2 value	P-value	+	χ2 value	P-value
Age (years)
<50	46	35	0.25	0.416	28	0.74	0.352
≥50	74	54			42
Menopause
Yes	52	38	1.36	0.129	30	0.62	0.391
No	68	51			40
Tumor size
<2 cm	44	29	5.24	0.017	23	8.49	0.013
≥2 cm	76	60			47
Lymph node metastasis
Yes	56	31	9.15	0.013	26	6.37	0.015
No	64	57			44
Histopathological grade
I	38	19	11.48	0.007	18	7.14	0.015
II	53	44			36
III	29	26			16
Tumor stage
I	32	18	12.53	0.007	16	9.61	0.011
II	57	43			33
III, IV	31	28			21
PR
(−)	48	35	0.94	0.172	28	1.74	0.114
(+)	72	54			42
ER
(−)	53	29	6.74	0.015	24	7.93	0.013
(+)	67	60			46
HER-2
(−)	52	38	0.87	0.181	30	0.96	0.172
(+)	68	51			40

SATB1, special AT-rich sequence-binding protein 1; TLR4, toll-like receptor 4.